Cognitive behaviour therapy for schizophrenia (Q24246180)

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. II: Predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Compliance therapy in psychotic patients: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Cognitive-behavioral therapy and clozapine for clients with treatment-refractory schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Cognitive therapy for schizophrenia: a preliminary randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Durability of the effects of cognitive-behavioural therapy in the treatment of chronic schizophrenia: 12-month follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Training persons with schizophrenia in illness self-management: a randomized controlled trial in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Computer-assisted cognitive rehabilitation reduces negative symptoms in the severely mentally ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

The omnipotence of voices. A cognitive approach to auditory hallucinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

A cognitive approach to measuring and modifying delusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Group Therapy and Maintenance Treatment of Schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Cognitive training adjunctive to pharmacotherapy in schizophrenia and depression: a pilot study on the lateralization hypothesis of schizophrenia and depression and on cognitive therapy as adjunctive to pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Cognitive behavioural therapy for drug-resistant psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

A controlled study of education about drug treatment in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Reduction of schizophrenic deficits by cognitive training: an evaluative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Medication and symptom management education program for the rehabilitation of psychiatric patients in Korea: the effects of promoting schedule on self-efficacy theory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Design prerequisites for research on cognitive therapy for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

A trial of two cognitive behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients. II. Treatment-specific changes in coping and problem-solving skills.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Technique for training schizophrenic patients in illness self-management: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Cognitive therapy of delusional beliefs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

When Symptoms Persist: Choosing Among Alternative Somatic Treatments for Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

21 January 2018

Insight and psychosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Antipsychotic drugs: clinical pharmacology and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Depression, hopelessness and suicide in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Treatment of the neuroleptic-nonresponsive schizophrenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

Cognitive behaviour therapy for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

A pilot study evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

A two-year prospective study of treatment compliance in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Development of specific social skills training programmes for schizophrenia patients: results of a multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

[Differentiated short- and long-term effects of a "Training of Emotional Intelligence" and of the "Integrated Psychologic Therapy Program" for schizophrenic patients?]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

A controlled trial of cognitive remediation in schizophrenia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

A Randomized Single-Blind Pilot Study of Compensatory Strategies in Schizophrenia Outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

A step forward in research on psychotherapy of schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

The use of cognitive behavior therapy with a normalizing rationale in schizophrenia. Preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

A comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Cognitive therapy with schizophrenic patients: conceptual basis, present state, future directions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Measuring delusional experiences: a method and its application

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Cognitive Therapy and Recovery from Acute Psychosis: a Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Randomised controlled trial of compliance therapy. 18-month follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

London-east Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. III: Follow-up and economic evaluation at 18 months

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Cognitive therapy and recovery from acute psychosis: A controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Cognitive–behavioural therapy in first-episode and early schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000524.PUB2

7 January 2021

Coping-skills training versus a problem-solving approach with schizophrenic patients.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000524.PUB2

A standardized psychiatric assessment scale for rating chronic psychotic patients

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD000524.PUB2

Identifiers

DOI

10.1002/14651858.CD000524.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3933285

OpenCitations bibliographic resource ID

3933285

1 reference